Treatment of rheumatoid arthritis with a DR4/1 peptide.

St Clair, E W; Cohen, S B; Lee, M L; Fleischmann, R M; Lee, S H; Moreland, L W; Olsen, N J; Pratt, P W; Yocum, D E; Heck, L; Winkelhake, J; Holcenberg, J S; Shulman, M J

St Clair, E W; Cohen, S B; Lee, M L; Fleischmann, R M; Lee, S H; Moreland, L W; Olsen, N J; Pratt, P W; Yocum, D E; Heck, L; Winkelhake, J; Holcenberg, J S; Shulman, M J.

Affiliation

St Clair EW; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. stcla003@mc.duke.edu

J Rheumatol ; 27(8): 1855-63, 2000 Aug.

Article in En | MEDLINE | ID: mdl-10955324

Subject(s)

Arthritis, Rheumatoid/therapy; HLA-DR4 Antigen/therapeutic use; Oligopeptides/therapeutic use; Adolescent; Adult; Aged; Arthritis, Rheumatoid/immunology; B-Lymphocytes/immunology; Double-Blind Method; Drug Therapy, Combination; Female; Flow Cytometry; HLA-DR4 Antigen/adverse effects; HLA-DR4 Antigen/immunology; Humans; Immunization, Secondary; Injections, Intramuscular; Lymphocyte Activation/immunology; Lymphocyte Count; Male; Methotrexate/therapeutic use; Middle Aged; Monocytes/immunology; Oligopeptides/adverse effects; Oligopeptides/immunology; Receptors, Antigen, T-Cell, alpha-beta/immunology; Safety; T-Lymphocytes/immunology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Arthritis, Rheumatoid / HLA-DR4 Antigen Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Rheumatol Year: 2000 Document type: Article Affiliation country: United States Country of publication: Canada

Search on Google

Add to My VHL

XML

PubMed Links